Channel One Style
SEE OTHER BRANDS

The latest news on culture, society and lifestyle

Channel One Style: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Channel One Style.

Press releases published on April 2, 2025

Pest Busterzz Launches Comprehensive Termite Control Services in South Florida

Pest Busterzz Launches Comprehensive Termite Control Services in South Florida

Tamarac, FL, April 02, 2025 (GLOBE NEWSWIRE) -- Pest Busterzz, a proud family-owned organic pest control company dedicated to offering eco-friendly and sustainable pest control solutions, is happy to announce the launch of its comprehensive termite control …

Palvella Therapeutics Announces Late-Breaking Oral Presentation at the 15th World Congress of Pediatric Dermatology

Palvella Therapeutics Announces Late-Breaking Oral Presentation at the 15th World Congress of Pediatric Dermatology

WAYNE, Pa., April 02, 2025 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from …

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

XOMA Royalty to Present at Jones Healthcare and Technology Innovation Conference

EMERYVILLE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (“XOMA”; NASDAQ: XOMA), the biotech royalty aggregator, announced today Chief Investment Officer, Brad Sitko, will be a featured presenter at the Jones Healthcare and …

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

Sensei Biotherapeutics to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that John Celebi, …

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

Pyxis Oncology to Participate in the Stifel 2025 Virtual Targeted Oncology Forum

BOSTON, April 02, 2025 (GLOBE NEWSWIRE) -- Pyxis Oncology, Inc. (Nasdaq: PYXS), a clinical-stage company developing next-generation therapeutics for difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President, Chief Executive Officer …

Bathroom Vanities Market Size to Reach US$ 52.90 Billion by 2031: In-Depth Research Report by The Insight Partners

Bathroom Vanities Market Size to Reach US$ 52.90 Billion by 2031: In-Depth Research Report by The Insight Partners

US …

Vital Signs Monitoring Devices Market Set to Reach USD 66.82 Billion by 2030, Growing at a CAGR of 12.7% - Exclusive Report by The Insight Partners

Vital Signs Monitoring Devices Market Set to Reach USD 66.82 Billion by 2030, Growing at a CAGR of 12.7% - Exclusive Report by The Insight Partners

US …

Marex Group plc provides preliminary Q1 results range and hosts Investor Day in New York

Marex Group plc provides preliminary Q1 results range and hosts Investor Day in New York

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Marex Group plc (Nasdaq: MRX) (‘Marex’), the diversified global financial services platform, provides a Q1 trading update at its Investor Day, being held today at the Nasdaq Marketsite in New York City. Marex …

Syntiant to Unveil Vision Transformer Security Solution at ISC West 2025

Syntiant to Unveil Vision Transformer Security Solution at ISC West 2025

IRVINE, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- Syntiant Corp., the recognized leader in low-power edge AI deployment, today announced it will demonstrate its multimodal vision transformer (ViT) at ISC West 2025 in Las Vegas, April 2-4. Deployed on an …

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum

Syndax Announces Participation at the Stifel 2025 Virtual Targeted Oncology Forum

NEW YORK, April 02, 2025 (GLOBE NEWSWIRE) -- Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of …

Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

Autolus Therapeutics to Participate in the 24th Annual Needham Virtual Healthcare Conference

LONDON, April 02, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies, announces that the Company will …

Green Thumb Industries to Hold First Quarter 2025 Earnings Conference Call on May 7, 2025

Green Thumb Industries to Hold First Quarter 2025 Earnings Conference Call on May 7, 2025

CHICAGO and VANCOUVER, British Columbia, April 02, 2025 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. (Green Thumb) (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer packaged goods company and owner of RISE Dispensaries, today announced it …

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting

Acumen Pharmaceuticals Showcases pTau217 Trial Screening Progress in Phase 2 ALTITUDE-AD Trial and Preclinical Research Methods at AD/PD 2025 and AAN Annual Meeting

NEWTON, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer …

Mekanism Merges with Camp Jefferson and Jungle to Form Mekanism Canada

Mekanism Merges with Camp Jefferson and Jungle to Form Mekanism Canada

NEW YORK and TORONTO, April 02, 2025 (GLOBE NEWSWIRE) -- Mekanism, the agency bringing Soul …

Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference

Vigil Neuroscience Presents Data on its Small Molecule TREM2 Agonist VG-3927 in Two Oral Presentations at AD/PD™ 2025 International Conference

- Preclinical presentation highlights key, modality specific, pharmacological differentiations of VG-3927 -  - First presentation of topline clinical data from Phase 1 SAD/MAD trial of VG-3927 for the potential treatment of Alzheimer’s disease (AD) - …

Norwegian Cruise Line Holdings Ltd. and NCL Corporation Ltd. Announce Exchangeable Notes Refinancing Transaction

Norwegian Cruise Line Holdings Ltd. and NCL Corporation Ltd. Announce Exchangeable Notes Refinancing Transaction

MIAMI, April 02, 2025 (GLOBE NEWSWIRE) -- Norwegian Cruise Line Holdings Ltd. (NYSE: NCLH) (the “Company”) and NCL Corporation Ltd., a subsidiary of the Company (“NCLC”), announce that NCLC has entered into individually negotiated note exchange agreements …

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

Tonix Pharmaceuticals to Present at the 2025 Jones Trading Healthcare and Innovation Conference

CHATHAM, N.J., April 02, 2025 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biopharmaceutical company with marketed products and a pipeline of development candidates, today announced that Seth Lederman M.D., …

Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference

Generation Bio to Present at the Needham 24th Annual Virtual Healthcare Conference

CAMBRIDGE, Mass., April 02, 2025 (GLOBE NEWSWIRE) -- Generation Bio Co. (Nasdaq:GBIO), a biotechnology company working to change what’s possible for people living with T cell-driven autoimmune diseases, announced that Geoff McDonough, M.D., president and …

Energy Management Systems Market Skyrockets to $105.2 Billion by 2031 | CAGR of 11.4% | Exclusive Report by The Insight Partners

Energy Management Systems Market Skyrockets to $105.2 Billion by 2031 | CAGR of 11.4% | Exclusive Report by The Insight Partners

US …

Parsons Selected for PFAS Investigation and Remedy Development at Tucson International Airport

Parsons Selected for PFAS Investigation and Remedy Development at Tucson International Airport

CHANTILLY, Va., April 02, 2025 (GLOBE NEWSWIRE) -- Parsons Corporation (NYSE: PSN) announced that the company was selected by Tucson Airport Authority (TAA), operator of Tucson International Airport (TUS), to execute a per- and polyfluoroalkyl substances ( …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service